BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31039222)

  • 1. What are the risks of long-term PPI use for GERD symptoms in patients > 65 years?
    Devitt J; Lyon C; Swanson SB; DeSanto K
    J Fam Pract; 2019 Apr; 68(3):E18-E19. PubMed ID: 31039222
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular Risk of Proton Pump Inhibitors.
    Ariel H; Cooke JP
    Methodist Debakey Cardiovasc J; 2019; 15(3):214-219. PubMed ID: 31687101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of proton-pump inhibitors in children with gastroesophageal reflux disease: a systematic review.
    van der Pol RJ; Smits MJ; van Wijk MP; Omari TI; Tabbers MM; Benninga MA
    Pediatrics; 2011 May; 127(5):925-35. PubMed ID: 21464183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What are the precautions with proton pump inhibitor use for reflux disease?
    Mospan CM
    JAAPA; 2015 Dec; 28(12):23-6. PubMed ID: 26595692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.
    Freedberg DE; Kim LS; Yang YX
    Gastroenterology; 2017 Mar; 152(4):706-715. PubMed ID: 28257716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of community-acquired pneumonia in veteran patients to whom proton pump inhibitors were dispensed.
    Hermos JA; Young MM; Fonda JR; Gagnon DR; Fiore LD; Lawler EV
    Clin Infect Dis; 2012 Jan; 54(1):33-42. PubMed ID: 22100573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do PPIs have long-term side effects? Nexium and the other proton-pump inhibitors are great at reducing stomach acid, but that might have some unintended consequences.
    Harv Health Lett; 2009 Jan; 34(3):4-5. PubMed ID: 19172761
    [No Abstract]   [Full Text] [Related]  

  • 8. Managing gastroesophageal reflux disease for the lifetime of the patient: evaluating the long-term options.
    Metz DC
    Am J Med; 2004 Sep; 117 Suppl 5A():49S-55S. PubMed ID: 15478853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the long term acid inhibitor treatment in gastroesophageal reflux disease? What are the potential problems related to long term acid inhibitor treatment in gastroesophageal reflux disease? How should these cases be followed?
    Hatemi İ; Esatoğlu SN
    Turk J Gastroenterol; 2017 Dec; 28(Suppl 1):S57-S60. PubMed ID: 29199170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of gastroesophageal reflux disease symptoms and effects of esomeprazole on the quality of life related to reflux and dyspepsia in patients on maintenance hemodialysis.
    Namikoshi T; Harada K; Hatta H; Tokura T; Oshiro Y; Nishizaki T; Obata T; Mori M; Fueki T; Fujimoto S; Haruna Y; Kuwabara A; Yorimitsu D; Ihoriya C; Kadoya H; Itano S; Fujimoto Y; Komai N; Sasaki T; Kashihara N
    Clin Exp Nephrol; 2016 Feb; 20(1):134-42. PubMed ID: 26026991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gastroesophageal reflux disease: pathogenetic basis of differentiated tactics of treatment].
    Tkachenko EI; Uspenskiĭ IuP; Karateev AE; Bakulin IG; Pakhomova IG
    Eksp Klin Gastroenterol; 2009; (2):104-14. PubMed ID: 19552028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Insufficient symptom control under long-term treatment with PPI in GERD - fact or fiction?].
    Labenz J; Labenz G; Stephan D; Willeke F;
    MMW Fortschr Med; 2016 May; 158 Suppl 4():7-11. PubMed ID: 27221555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton Pump Inhibitors in Gastroesophageal Reflux Disease: Friend or Foe.
    Gyawali CP
    Curr Gastroenterol Rep; 2017 Sep; 19(9):46. PubMed ID: 28780717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gastroesophageal reflux disease: surgical or medical treatment? - Medical].
    Schepp W
    Dtsch Med Wochenschr; 2014 May; 139(17):892. PubMed ID: 24760692
    [No Abstract]   [Full Text] [Related]  

  • 15. Proton pump inhibitor monotherapy and the risk of cardiovascular events in patients with gastro-esophageal reflux disease: a meta-analysis.
    Sun S; Cui Z; Zhou M; Li R; Li H; Zhang S; Ba Y; Cheng G
    Neurogastroenterol Motil; 2017 Feb; 29(2):. PubMed ID: 27577963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease.
    Higginbotham TW
    Ann Pharmacother; 2010 Mar; 44(3):572-6. PubMed ID: 20124466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acid suppression and pneumonia.
    Brandt D
    Am J Nurs; 2005 Feb; 105(2):21. PubMed ID: 15674045
    [No Abstract]   [Full Text] [Related]  

  • 18. [Potential risks associated with long-term PPI use].
    Kamiya T
    Nihon Rinsho; 2016 Aug; 74(8):1387-1391. PubMed ID: 30562448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Refractory gastroesophageal reflux disease (GERD) and PPI safety].
    Huerta-Iga FM
    Rev Gastroenterol Mex; 2013 Aug; 78 Suppl 1():1-3. PubMed ID: 24041041
    [No Abstract]   [Full Text] [Related]  

  • 20. Pro: Impedance testing is useful in the management of GERD.
    Blondeau K; Tack J
    Am J Gastroenterol; 2009 Nov; 104(11):2664-6. PubMed ID: 19888230
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.